by Rebekkah Huss | Jan 10, 2022 | Blog
Dr. Luca Pani of WCG VeraSci co-authored an article discussing the connection between Darwinian evolution and the SARS-Cov-2 virus. Excerpt: “In short, Pasteur allowed us to imagine and build vaccines or drugs, while Darwin explained, with his theory of natural... by Rebekkah Huss | Dec 7, 2021 | Posters
WCG VeraSci is pleased to share results from a recent study examining the feasibility and reliability of remote, in-home self-administration of cognitive tests using the Pathway ePRO platform. Sixty-one older adults with and without subjective cognitive decline... by Rebekkah Huss | Dec 8, 2020 | Blog, Press Releases
Neuropsychopharmacology recently published “Placebo Response Mitigation with a Participant-Focused Psychoeducational Procedure: A Randomized, Single-Blind, All Placebo Study in Major Depressive and Psychotic Disorders”. Dr. Bill Horan, Vice President Clinical Science... by Rebekkah Huss | Aug 4, 2020 | Blog
The Expanded Disability Status Scale (EDSS) is one of the most widely used endpoints in multiple sclerosis (MS) research and in clinical trials of investigational treatments for MS. The EDSS is an elaborate scoring system applied to a neurological examination that... by Rebekkah Huss | Jul 14, 2020 | Press Releases
VeraSci, a leading provider of innovative scientific and technology services, announced today the expansion of their proprietary eCOA platform to fully integrate the Neurostatus-EDSS assessment and Neurostatus data clarification services for MS trials. VeraSci...